Homology Medicines Inc (DELISTED) (FIXX:DL)
0.9347
-15.76
(-94.40%)
USD |
NASDAQ |
Mar 25, 16:00
0.92
-0.01
(-1.57%)
After-Hours: 20:00
Homology Medicines Cash from Investing (TTM): 101.33M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 101.33M |
| September 30, 2023 | 87.60M |
| June 30, 2023 | 2.146M |
| March 31, 2023 | -100.22M |
| December 31, 2022 | 36.72M |
| September 30, 2022 | 62.39M |
| June 30, 2022 | 175.13M |
| March 31, 2022 | 202.76M |
| December 31, 2021 | -50.79M |
| September 30, 2021 | -95.40M |
| June 30, 2021 | -61.08M |
| March 31, 2021 | 4.664M |
| December 31, 2020 | 204.90M |
| Date | Value |
|---|---|
| September 30, 2020 | 185.82M |
| June 30, 2020 | 133.84M |
| March 31, 2020 | 43.53M |
| December 31, 2019 | -51.80M |
| September 30, 2019 | -21.57M |
| June 30, 2019 | -53.69M |
| March 31, 2019 | -108.76M |
| December 31, 2018 | -121.79M |
| September 30, 2018 | -211.89M |
| June 30, 2018 | -166.94M |
| March 31, 2018 | -74.04M |
| December 31, 2017 | -81.53M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-100.22M
Minimum
Mar 2023
204.90M
Maximum
Dec 2020
42.43M
Average
36.72M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
| Societal CDMO Inc (DELISTED) | -8.237M |
| AgeX Therapeutics Inc (DELISTED) | -10.00M |
| NovaBay Pharmaceuticals Inc | 1.062M |
| Palatin Technologies Inc | 9.293M |
| iBio Inc | 8.285M |